ReviewJournal of hematology & oncology2019
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics.
Akintunde Akinleye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
395 papers cite itlatest 60 shown
this paperpooled ittrialcites it